.png){kind=small}
invitrace at ICHOM 2025: Driving Measurable Impact in Value-Based Healthcare
- Invitrace public relation editor
- 7 hours ago
- 1 min read
From 29 September to 1 October 2025, Invitrace participated in ICHOM 2025 (International Consortium for Health Outcomes Measurement) in Dublin, Ireland, engaging with global healthcare leaders to advance the principles of Value-Based Healthcare (VBHC) — a model that places patient-reported outcomes at the center of meaningful, high-value care.
During the conference, Mr. Supanudh Vitheethum, Lead Global Business Development (UK) of Invitrace, and Dr. Chantas Mahaisavariya, Special Assistant Professor of Orthopaedic Surgery, Mahidol University,presented a research abstract titled “Improvement of Anti-osteoporosis Medication Rate in Osteoporosis Patients After Implementation of an Assisted Liaison Service Application.”
The study highlighted the utilization of the WellHealth Platform — Invitrace’s AI-enabled solution designed to support precise outcome measurement, enhance data connectivity, and empower healthcare professionals with actionable insights that strengthen care delivery.
At Invitrace, we design technology that truly listens to patients — and we cultivate a culture where meaningful care begins with understanding. Every voice matters, and every outcome fuels the digital transformation and performance-driven innovations that continue to elevate modern healthcare.
Comments